These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37211905)

  • 1. Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients.
    Oku Y; Toyokawa G; Wakasu S; Kinoshita F; Takamori S; Watanabe K; Haratake N; Nagano T; Kosai K; Takada K; Fujimoto A; Higashijima K; Shiraishi Y; Tanaka K; Takeoka H; Okamoto M; Yamashita T; Shimokawa M; Shoji F; Yamazaki K; Okamoto T; Seto T; Ueda H; Takeo S; Nakashima N; Okamoto I; Takenaka T; Yoshizumi T
    Cancer Med; 2023 Jul; 12(13):14327-14336. PubMed ID: 37211905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
    Nishihara-Kato F; Imai H; Tsuda T; Wasamoto S; Nagai Y; Kishikawa T; Miura Y; Ono A; Yamada Y; Masubuchi K; Osaki T; Nakagawa J; Umeda Y; Minemura H; Kozu Y; Taniguchi H; Ohta H; Kaira K; Kagamu H
    Oncology; 2024; 102(1):30-42. PubMed ID: 37598676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.
    Zhang Y; Kong FF; Zhu ZQ; Shan HX
    BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of inflammation and nutritional index in immunotherapy for stage IV non-small cell lung cancer and model construction.
    Lei W; Wang W; Qin S; Yao W
    Sci Rep; 2024 Jul; 14(1):17511. PubMed ID: 39080372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Nutritional Index before durvalumab after chemoradiation predict the overall survival in patients with stage III non-small cell lung cancer.
    Matsuura S; Serizawa S; Yamashita R; Morikawa K; Ito Y; Hiramatsu T; Mochizuki E; Tanaka K; Akiyama N; Tsukui M; Koshimizu N; Kosugi T
    Ann Med; 2023 Dec; 55(1):2196089. PubMed ID: 37043179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
    Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M
    Front Oncol; 2023; 13():1041140. PubMed ID: 37007079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Nutritional Indices With Adverse Effects and Time-to-Treatment-Failure in Triple Therapy for Lung Cancer.
    Hashino Y; Matushita T; Hatsuyama T; Wakamoto A; Goto K; Hoshi T; Iwayama K; Ohtaki K; Toda T; Sato H
    In Vivo; 2024; 38(2):864-872. PubMed ID: 38418111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of nutritional and inflammatory biomarkers with overall survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors.
    Horstman IM; Vinke PC; Suazo-Zepeda E; Hiltermann TJN; Heuvelmans MA; Corpeleijn E; de Bock GH
    Thorac Cancer; 2024 Aug; 15(23):1764-1771. PubMed ID: 39030876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
    Xia H; Zhang W; Zheng Q; Zhang Y; Mu X; Wei C; Wang X; Liu Y
    Heliyon; 2023 Aug; 9(8):e17400. PubMed ID: 37520982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment "prognostic nutritional index" as an indicator of outcome in lung cancer patients receiving ICI-based treatment: Systematic review and meta-analysis.
    Shao Y; Cao W; Gao X; Tang M; Zhu D; Liu W
    Medicine (Baltimore); 2022 Oct; 101(43):e31113. PubMed ID: 36316884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors.
    Peng L; Wang Y; Liu F; Qiu X; Zhang X; Fang C; Qian X; Li Y
    Cancer Immunol Immunother; 2020 Sep; 69(9):1813-1822. PubMed ID: 32350592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors.
    Yan X; Wang J; Mao J; Wang Y; Wang X; Yang M; Qiao H
    Front Nutr; 2023; 10():1213255. PubMed ID: 37575320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer.
    Ogura Y; Kataoka N; Kunimatsu Y; Tachibana Y; Sugimoto T; Tani N; Sato I; Hirose K; Kato D; Takeda T
    Thorac Cancer; 2021 Jan; 12(1):97-105. PubMed ID: 33124197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer.
    Stares M; Ding TE; Stratton C; Thomson F; Baxter M; Cagney H; Cumming K; Swan A; Ross F; Barrie C; Maclennan K; Campbell S; Evans T; Tufail A; Harrow S; Lord H; Laird B; MacKean M; Phillips I
    ESMO Open; 2022 Apr; 7(2):100445. PubMed ID: 35398717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy.
    Pan Y; Ma Y; Dai G
    Nutrients; 2023 Oct; 15(19):. PubMed ID: 37836573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Nutritional Index Associates with Immunotherapy Response in Patients with Metastatic Biliary Tract Cancer.
    Yang L; Zhong J; Wang W; Zhou F
    Nutr Cancer; 2023; 75(2):696-706. PubMed ID: 36511876
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploration of immunotherapy in advanced pulmonary lymphoepithelioma-like carcinoma.
    Pang LL; Liao J; Huang YH; Gan JD; Zhuang WT; Lv Y; Liang WT; Zhang L; Fang WF
    Int J Cancer; 2023 Jun; 152(11):2338-2350. PubMed ID: 36631999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.